The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index, and 1 are not checked yet.
Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.
Open accessAbstract
Neurofibrillary tangles (NFT) and neurites associated with senile plaques (SP) in Alzheimer disease-affected brain tissues were specifically immunostained with affinity-purified antibody preparations directed against ubiquitin. In addition, a class of neurites seen in brain regions containing NFT and SP were also specifically stained. Cross-reactivity of the ubiquitin antisera for tau protein, neurofilament proteins, and high molecular weight microtubule-associated proteins (MAPs) were ruled out by (i) the inability of the ubiquitin antisera to stain these proteins in immunoblotting experiments and (ii) the inability of tau, neurofilament, and MAP preparations, when preincubated with the ubiquitin antisera, to inhibit the selective neurofibrillar staining observed. Our results are consistent with the suggestion that ubiquitin is covalently associated with the insoluble neurofibrillary material of NFT and SP. We propose that the ubiquitin-mediated degradative pathway may be ineffective in removing these fibrillar structures in Alzheimer disease brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Amyloid Deposits and Amyloidosis
Glenner, G. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006053022305 · Cited by 1,780
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,491
Phosphorylation affects the ability of tau protein to promote microtubule assembly.
Lindwall, G., & Cole, R. D. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42989-9 · Cited by 901
Hershko, A., Ciechanover, A. J., Heller, H., Haas, A. L., & Rose, I. A. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.4.1783 · Cited by 769
Wood, J. G., Mirra, S. S., Pollock, N. J., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4040 · Cited by 763
Mechanisms of Intracellular Protein Breakdown
Hershko, A., & Ciechanover, A. J. (1982) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.51.070182.002003 · Cited by 650
Ciechanover, A. J., Finley, D. J., & Varshavsky, A. J. (1984) · Cell · doi:10.1016/0092-8674(84)90300-3 · Cited by 532
Amyloid Deposits and Amyloidosis
Glenner, G. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006123022403 · Cited by 515
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 629
Immunohistochemical and Ultrastructural Studies
Kikuchi, A., Akiyama, M., Hanyaku, H., Shimizu, H., Naka, W., & Nishikawa, T. (1993) · American Journal of Dermatopathology · doi:10.1097/00000372-199302000-00003 · Cited by 71
Moechars, D., Lorent, K., & Leuven, F. V. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00599-5 · Cited by 69
Antioxidant protection and neurodegenerative disease: The role of amyloid-β and tau
Castellani, R. J., Lee, H., Perry, G. L., & Smith, M. A. (2006) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750602100213 · Cited by 72
Self-citationHong, X., Liu, J., Zhu, G., Zhuang, Y., Suo, H., Wang, P., Huang, D., Xu, J., Huang, Y., Yu, M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt501 · Cited by 73
Perry, G. L., Mulvihill, P., Fried, V. A., Smith, H. T., Grundke, I., & Iqbal, K. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09203.x · Cited by 69
Self-citationSnow, A. D., Lara, S. L., Nochlin, D., & Wight, T. N. (1989) · Acta Neuropathologica · doi:10.1007/bf00688198 · Cited by 69
Alzheimer’s Disease: A Clinical Practice-Oriented Review
Alves, L., Correia, A. S., Miguel, R., Alegria, P., & Bugalho, P. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00063 · Cited by 74
Degradation or aggregation: the ramifications of post-translational modifications on tau
Park, S., Lee, J. H., Jeon, J. H., & Lee, M. J. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.6.077 · Cited by 73
Isolation of a major protein component of Rosenthal fibers.
Goldman, J. E., & Corbin, E. (1988) · PubMed Central · Cited by 68
Ubiquitin, cell stress and diseases of the nervous system
Lowe, J. S., & Mayer, R. J. (1990) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1990.tb01263.x · Cited by 68
BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease
Evans, T. A., Raina, A. K., Delacourte, A., Aprelikova, O. N., Lee, H., Zhu, X., Perry, G. L., & Smith, M. A. (2007) · International Journal of Medical Sciences · doi:10.7150/ijms.4.140 · Cited by 66
Self-citationRoertgen, K. E., Parisi, J. E., Clark, H. B., Barnes, D. L., O’Brien, T. D., & Johnson, K. H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02069-1 · Cited by 67
An immunochemical study on tau glycation in paired helical filaments
Ko, L., Ko, E. C., Nacharaju, P., Liu, W.-K., Chang, E. C., Kenessey, Á., & Yen, S.-H. C. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01415-8 · Cited by 68
Casein kinase II alteration precedes tau accumulation in tangle formation.
Masliah, E., Iimoto, D. S., Mallory, M. E., Albright, T., Hansen, L. A., & Saitoh, T. (1992) · PubMed Central · Cited by 66
Nunan, J., Williamson, N. A., Hill, A. F., Sernee, M. F., Masters, C. L., & Small, D. H. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10646 · Cited by 66
The Role of Ubiquitin-Protein Ligases in Neurodegenerative Disease
Ardley, H. C., & Robinson, P. A. (2004) · Neurodegenerative Diseases · doi:10.1159/000080048 · Cited by 67
Wagner, L. K., Gilling, K. E., Schormann, E., Kloetzel, P. M., Heppner, F. L., Krüger, E., & Prokop, S. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0453-5 · Cited by 67
Dam, D. V., Vermeiren, Y., Dekker, A. D., Naudé, P. J. W., & Deyn, P. P. D. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160502123607 · Cited by 68
Ahlgren, S., Li, G. L., & Olsson, Y. (1996) · Acta Neuropathologica · doi:10.1007/s004010050488 · Cited by 65
Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease.
Bondareff, W., Wischik, C. M., Novák, M., & Roth, M. (1991) · PubMed Central · Cited by 64
Alzheimer's disease meets the ubiquitin–proteasome system
Song, S., & Jung, Y. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.005 · Cited by 66
PI31 Is an Adaptor Protein for Proteasome Transport in Axons and Required for Synaptic Development
Liu, K., Jones, S. K., Minis, A., Rodriguez, J., Molina, H., & Steller, H. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.06.009 · Cited by 66
Ubiquitous variations in nerves
Gallo, J., & Anderton, B. H. (1989) · Nature · doi:10.1038/337687a0 · Cited by 64
Jung, E. S., Hong, H., Kim, C., & Mook‐Jung, I. (2015) · Scientific Reports · doi:10.1038/srep08805 · Cited by 64
Schmidt, M. L., Gur, R. E., Gur, R. C., & Trojanowski, J. Q. (1988) · Annals of Neurology · doi:10.1002/ana.410230212 · Cited by 63
Ivy, G. O., Kitani, K., & Ihara, Y. (1989) · Brain Research · doi:10.1016/0006-8993(89)91117-7 · Cited by 62
Uney, J. B., Leigh, P. N., MARSDEN, C. D., Lees, A. J., & Anderton, B. H. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81265-1 · Cited by 63
Kumar, P., Pradhan, K., Ramani, K., Ambasta, R. K., & Querfurth, H. W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07588.x · Cited by 61
Wilhelmus, M. M. M., Nijland, P. G., Drukarch, B., de Vries, H. E., & van Horssen, J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.040 · Cited by 62
In situ hybridization histochemistry and the study of gene expression in the human brain
Harrison, P. J., & PEARSON, R. (1990) · Progress in Neurobiology · doi:10.1016/0301-0082(90)90007-4 · Cited by 61
Brion, J., Couck, A., Robertson, J., Loviny, T. L. F., & Anderton, B. H. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03298.x · Cited by 61
Pathology of Parkinson’s Syndrome
Jellinger, K. A. (1989) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-73899-9_2 · Cited by 59
Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum
Shahheydari, H., Ragagnin, A., Walker, A. K., Toth, R. P., Vidal, M., Jagaraj, C. J., Perri, E. R., Konopka, A., Sultana, J. M., & Atkin, J. D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00119 · Cited by 61
Gene Synthesis, Expression, and Processing of Human Ubiquitin Carboxyl Extension Proteins
Monia, B. P., Ecker, D. J., Jonnalagadda, S. A., Marsh, J., Gotlib, L., Butt, T. R., & Crooke, S. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84967-0 · Cited by 59
Pappas, B., Yang, Y., Wang, Y., Kim, K., Chung, H. J., Cheung, M., Ngo, K., Shinn, A. H., & Chan, W. K. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.015 · Cited by 60
Shi, Q., Prior, M., He, W., Tang, X., Hu, X., & Yan, R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5741-08.2009 · Cited by 59
Shaw, G., & Chau, V. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2854 · Cited by 57
Self-citationÖhrfelt, A., Johansson, P., Wallin, A., Andréasson, U., Zetterberg, H., Blennow, K., & Svensson, J. (2016) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000447239 · Cited by 59
Transcriptional activation of Alzheimer's β-amyloid precursor protein gene by stress
Dewji, N. N., Do, C., & Bayney, R. M. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00131-b · Cited by 57
Caspase‐6 as a novel early target in the treatment of Alzheimer's disease
LeBlanc, A. C. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12250 · Cited by 56
Proteolytic Cleavage of Polymeric Tau Protein by Caspase-3: Implications for Alzheimer Disease
Jarero-Basulto, J. J., Luna‐Muñoz, J., Mena, R., Krištofíková, Z., Řípová, D., Perry, G. L., Binder, L. I., & García‐Sierra, F. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000013 · Cited by 55
Self-citationPreventing P-gp Ubiquitination Lowers Aβ Brain Levels in an Alzheimer’s Disease Mouse Model
Hartz, A. M. S., Zhong, Y., Shen, A. N., Abner, E. L., & Bauer, B. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00186 · Cited by 54
Yagami, T., Yamamoto, Y., & Koma, H. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1277-4 · Cited by 56
Neuropathology of Down syndrome and Alzheimer disease
Cork, L. C. (2005) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320370756 · Cited by 54
Matsumoto, S., Hirano, A., & Goto, S. (1990) · Acta Neuropathologica · doi:10.1007/bf00294639 · Cited by 52
Iqbal, K., Braak, E., Braak, H., Zaidi, T., & Grundke, I. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90022-c · Cited by 57
The human ubiquitin carrier protein E2(Mr = 17,000) is homologous to the yeast DNA repair gene RAD6.
Schneider, R., Eckerskorn, C., Lottspeich, F., & Schweiger, M. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08259.x · Cited by 54
Halawani, D., Tessier, S., Anzellotti, D., Bennett, D. A. A., Latterich, M., & LeBlanc, A. C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5874-09.2010 · Cited by 54
Stress protein expression in the Alzheimer-diseased choroid plexus
Anthony, S. G., Schipper, H. M., Tavares, R., Hovanesian, V., Cortez, S. C., Stopa, E. G., & Johanson, C. E. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5301 · Cited by 52
Monoclonal antibodies to purified cortical lewy bodies recognize the mid‐size neurofilament subunit
Galvin, J. E., Lee, V. M. ‐., Baba, M., Mann, D. M. A., Dickson, D. W., Yamaguchi, H., Schmidt, M. L., Iwatsubo, T., & Trojanowski, J. Q. (1997) · Annals of Neurology · doi:10.1002/ana.410420410 · Cited by 51
Cerebrospinal fluid and blood biomarkers in Alzheimer’s disease
Humpel, C. (2011) · World Journal of Psychiatry · doi:10.5498/wjp.v1.i1.8 · Cited by 54
The self-perpetuating tau truncation circle
Žilka, N., Kováčech, B., Baráth, P., Kontseková, E., & Novák, M. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120015 · Cited by 56
Witte, M. E., Bol, J. G. J. M., Gerritsen, W. H., van der Valk, P., Drukarch, B., van Horssen, J., & Wilhelmus, M. M. M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.08.009 · Cited by 53
Kwak, S., Masaki, T., Ishiura, S., & Sugita, H. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90751-e · Cited by 50
What do we really know about amyotrophic lateral sclerosis?
Swash, M., & Schwartz, M. S. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90258-m · Cited by 50
Marked increase in cerebrospinal fluid ubiquitin in Creutzfeldt-Jakob disease
Manaka, H., Kato, T., Kurita, K., Katagiri, T., Shikama, Y., Kujirai, K., Kawanami, T., Suzuki, Y., Nihei, K., Sasaki, H., et al. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90854-z · Cited by 48
Bizzi, A., Schaetzle, B., Patton, A., Gambetti, P. L., & AUTILIO‐GAMBETTI, L. (1991) · Brain Research · doi:10.1016/0006-8993(91)91135-n · Cited by 48
Protein processing in lysosomes: the new therapeutic target in neurodegenerative disease
Mayer, R. J., Landon, M., László, L., Lowe, J. S., & Lennox, G. G. (1992) · The Lancet · doi:10.1016/0140-6736(92)93224-b · Cited by 48
Biology of Disease Human Amyloidosis, Alzheimer Disease and Related Disorders
Castaño, E. M., & Frangione, B. (1989) · Cited by 48
Modeling Prion-Like Processing of Tau Protein in Alzheimer’s Disease for Pharmaceutical Development
Wischik, C. M., Schelter, B. O., Wischik, D., Storey, J. M. D., & Harrington, C. R. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170727 · Cited by 49
Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD
Mattson, M. P. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(94)00182-z · Cited by 47
Immunochemical demonstration of tropomyosin in the neurofibrillary pathology of Alzheimer's disease.
Galloway, P. G., Mulvihill, P., Siedlak, S. L., Mijares, M., Kawai, M., Padget, H., Kim, R., & Perry, G. L. (1990) · Europe PMC (PubMed Central) · Cited by 47
Self-citationAlzheimer's disease: paired helical filament immunoreactivity in cerebrospinal fluid
Wang, G. P., Iqbal, K., Bucht, G., Winblad, B. G., Wisniewski, H. M., & Grundke, I. (1991) · Acta Neuropathologica · doi:10.1007/bf00310917 · Cited by 47
Uchida, K., NAKAYAMA, H., TATEYAMA, S., & Naoaki, G. O. T. O. (1992) · Journal of Veterinary Medical Science · doi:10.1292/jvms.54.1023 · Cited by 47
Immunological demonstration of tau protein in neurofibrillary tangles of Alzheimer's disease
Brion, J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s321 · Cited by 55
Proteomics of Alzheimer’s disease: understanding mechanisms and seeking biomarkers
Lovestone, S., Güntert, A., Hye, A., Lynham, S., Thambisetty, M., & Ward, M. A. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.2.227 · Cited by 46
The neurochemistry of Alzheimer's disease
Blennow, K., & Cowburn, R. F. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb00378.x · Cited by 46
Murphy, G. M., Eng, L. F., Ellis, W. G., Perry, G. L., Meissner, L. C., & Tinklenberg, J. R. (1990) · Brain Research · doi:10.1016/0006-8993(90)90345-c · Cited by 46
Self-citationInfluence of neuronal location on antigenic properties of neurofibrillary tangles
Tabaton, M., Perry, G. L., AUTILIO‐GAMBETTI, L., Manetto, V., & Gambetti, P. L. (1988) · Annals of Neurology · doi:10.1002/ana.410230613 · Cited by 46
Self-citationIn Vitro and In Vivo Activation of Astrocytes by Amyloid-β is Potentiated by Pro-Oxidant Agents
García‐Matas, S., de Vera, N., Aznar, A. O., Marimon, J. M., Adell, A., Planas, A. M., Cristòfol, R. M., & Sanfeliu, C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1365 · Cited by 45
Sequestosome 1/p62: across diseases
Geetha, T., Viswaprakash, N., Sycheva, M., & Babu, J. R. (2012) · Biomarkers · doi:10.3109/1354750x.2011.653986 · Cited by 48
Dennissen, F. J. A., Kholod, N., Hermes, D. J. H. P., Kemmerling, N., Steinbusch, H. W. M., Dantuma, N. P., & van Leeuwen, F. W. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.06.037 · Cited by 45
Shin, R., Bramblett, G. T., Lee, V. M., & Trojanowski, J. Q. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6825 · Cited by 45
Roher, A. E., Palmer, K. C., Chau, V., & Ball, M. J. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.6.2703 · Cited by 45
Self-citationUbiquitin conjugate immunoreactivity in the brains of scrapie infected mice
Lowe, J. S., McDermott, H., Kenward, N., Landon, M., Mayer, R. J., Bruce, M. E., McBride, P., Somerville, R. A., & Hope, J. (1990) · The Journal of Pathology · doi:10.1002/path.1711620112 · Cited by 45
Protein clearance strategies for disease intervention
Hommen, F., Bilican, S., & Vílchez, D. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02431-y · Cited by 48
Emerging role of Alzheimer's disease-associated ubiquilin-1 in protein aggregation
Haapasalo, A., Viswanathan, J., Bertram, L., Soininen, H. S., Tanzi, R. E., & Hiltunen, M. O. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380150 · Cited by 46
Carter, C. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.003 · Cited by 44
Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat
Dewar, D., Graham, D. I., Teasdale, G. M., & McCulloch, J. (1993) · Acta Neuropathologica · doi:10.1007/bf00294302 · Cited by 44
Fonseca, M. I., McGuire, S. O., Counts, S., & Tenner, A. J. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-25 · Cited by 43
Cholinesterases colocalize with sites of neurofibrillary degeneration in aged and Alzheimer's brains
Mor�n, M. A., Mufson, E. J., & Gómez‐Ramos, P. (1994) · Acta Neuropathologica · doi:10.1007/bf00296744 · Cited by 43
Mattson, M. P., Lovell, M. A., Ehmann, W. D., & Markesbery, W. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90236-g · Cited by 43
Ubiquitin in homeostasis, development and disease
Muller, S., & Schwartz, L. M. (1995) · BioEssays · doi:10.1002/bies.950170804 · Cited by 43
Ojelade, S. A., Lee, T. V., Giagtzoglou, N., Yu, L., Ugur, B., Li, Y., Duraine, L., Zuo, Z., Petyuk, V., De Jager, P. L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.041 · Cited by 42
To target Tau pathologies, we must embrace and reconstruct their complexities
Limorenko, G., & Lashuel, H. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105536 · Cited by 41
Developing pharmacological therapies for Alzheimer disease
Iqbal, K., & Grundke, I. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7221-9 · Cited by 42
Sperm ubiquitination in patients with dysplasia of the fibrous sheath
Rawe, V. Y. (2002) · Human Reproduction · doi:10.1093/humrep/17.8.2119 · Cited by 42
Muñoz, D. G., & Wang, D. (1992) · PubMed · Cited by 42
Regenerative Failure: A Potential Mechanism for Neuritic Dystrophy in Alzheimer's Disease
DeWitt, D. A., & Silver, J. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0182 · Cited by 42
Ubiquitin in Cerebrospinal Fluid in Alzheimer ’s Disease and Vascular Dementia
Blennow, K., Davidsson, P., Wallin, A., Gottfries, C., & Svennerholm, L. T. (1994) · International Psychogeriatrics · doi:10.1017/s1041610294001584 · Cited by 41
Gómez‐Ramos, P., Mufson, E. J., & Moran, M. A. (1992) · Brain Research · doi:10.1016/0006-8993(92)90634-l · Cited by 41
The carboxyl extension of a ubiquitin-like protein is rat ribosomal protein S30.
Olvera, J., & Wool, I. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46799-8 · Cited by 40
Protein SUMOylation in neuropathological conditions
Anderson, D. B., Wilkinson, K. A., & Henley, J. M. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.5.1378636 · Cited by 39
Reiner, A. J., Mar, N. D., Deng, Y., Meade, C. A., Sun, Z., & Goldowitz, D. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21515 · Cited by 38
Madadi, S., Schwarzenbach, H., Saidijam, M., Mahjub, R., & Soleimani, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0354-3 · Cited by 41
Sun, Y., Yan, C., He, L., Xiang, S., Wang, P., Li, Z., Chen, Y., Zhao, J., Yuan, Y., Wang, W., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101899 · Cited by 40
Poly-ubiquitin profile in Alzheimer disease brain
Tramutola, A., Triani, F., Domenico, F. D., Barone, E., Cai, J., Klein, J. B., Marzia Perluigi, A., & Butterfield, D. A. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.006 · Cited by 38
Sai, X., Kokame, K., Shiraishi, H., Kawamura, Y., Miyata, T., Yanagisawa, K., & Komano, H. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01009-3 · Cited by 38
Post-translational modifications in neurodegeneration
Didonna, A., & Benetti, F. (2015) · AIMS Biophysics · doi:10.3934/biophy.2016.1.27 · Cited by 36
Schaler, A. W., & Myeku, N. (2017) · Translational research · doi:10.1016/j.trsl.2017.11.004 · Cited by 34
Metadata
- Authors
- Perry, G., Friedman, R., Shaw, G., & Chau, V
- Affiliations
- Case Western Reserve University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1987-05
- Volume
- 84
- Issue
- 9
- Pages
- 3033-3036
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC304795
- OpenAlex
- W2046720254
- Cited by
- 623
- References
- 27
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 11 · 2023: 13 · 2022: 8 · 2021: 15 · 2020: 17 · 2019: 15 · 2018: 21 · 2017: 11 · 2016: 17 · 2015: 15 · 2014: 5 · 2013: 20 · 2012: 18
- FWCI
- 33.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG00795)
- National Institute of General Medical Sciences (GM35803)
- National Institute of Neurological Disorders and Stroke (NS22695)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- ubiquitin, neurofibrillary tangles, amyloid plaques, Alzheimer's disease, neurites, protein degradation, tau protein, neurofilaments, microtubule-associated proteins, immunostaining
- MeSH terms
- Aged, Alzheimer Disease, Antibodies, Antigen-Antibody Complex, Axons, Brain, Humans, Immunoenzyme Techniques, Neurons, Ubiquitins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review